Global safety in adalimumab (HUMIRA®) rheumatoid arthritis clinical trials.

被引：0
|
作者：
Schiff, MH
Burmester, GR
Pangan, AL
Kupper, H
Spencer-Green, GT
机构：
[1] Denver Arthrit Clin PC, Denver, CO USA
[2] Univ Klinikum, Charite, Berlin, Germany
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Abbott Labs, Ludwigshafen, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S562 / S562
页数：1
相关论文
共 50 条
  • [41] Safety of Adalimumab in Global Clinical Trials of Patients with Crohn's Disease
    Colombel, Jean-Frederic
    Rutgeerts, Paul
    Sandborn, William J.
    Rutgeerts, Paul J.
    Hanauer, Stephen B.
    Reinisch, Walter
    Pollack, Paul F.
    Kent, Jeffrey D.
    Cardoso, Alexandra T.
    Lau, Winnie
    GASTROENTEROLOGY, 2009, 136 (05) : A651 - A651
  • [42] Adalimumab Safety in Global Clinical Trials of Patients with Crohn's Disease
    Colombel, Jean-Frederic
    Sandborn, William J.
    Panaccione, Remo
    Robinson, Anne M.
    Lau, Winnie
    Li, Ju
    Cardoso, Alexandra T.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (09) : 1308 - 1319
  • [43] Adalimumab (Humira®) plus methotrexate in patients with rheumatoid arthritis:: Continued efficacy up to 4 years in open-label trials
    Schiff, MH
    Weisman, M
    Furst, DE
    Kavanaugh, A
    Spencer-Green, G
    Perez, JL
    Segurado, OG
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 269 - 269
  • [44] Safety of Adalimumab in Global Clinical Trials of Patients with Crohn's Disease
    Colombel, Jean-Frederic
    Panaccione, Remo
    Sandborn, William
    Rutgeerts, Paul
    Hanauer, Stephen
    Reinisch, Walter
    Robinson, Anne
    Lau, Winnie
    Cardoso, Alexandra
    Pollack, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S413 - S414
  • [45] Efficacy and safety of adalimumab (Humira®) in European clinical practice:: The ReAct trial
    Burmester, GR
    Wordsworth, P
    Mariette, X
    Sáez, IM
    Bijlsma, JWJ
    Webber, DG
    Kupper, H
    RHEUMATOLOGY, 2005, 44 : I23 - I24
  • [46] SUSTAINED EFFICACY OF ADALIMUMAB (HUMIRA®) PLUS METHOTREXATE (MTX) IN RHEUMATOID ARTHRITIS (RA) PATIENTS
    Schiff, M. H.
    Weisman, M.
    Furst, D. E.
    Kavanaugh, A.
    Spencer-Green, G.
    Segurado, O. G.
    RHEUMATOLOGY, 2004, 43 : 40 - 40
  • [47] Efficacy and safety of adalimumab (HUMIRA®) in European clinical practice:: The react trial
    Burmester, GR
    Sáez, IM
    Malaise, M
    da Silva, JC
    Webber, DG
    Kupper, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 90 - 90
  • [48] SAFETY OF LEFLUNOMIDE IN RHEUMATOID ARTHRITIS; FROM CLINICAL TRIALS TO CLINICAL PRACTICE
    Hassan, Al
    Galarraga, B.
    Jordan, K. M.
    Armstrong, R. D.
    RHEUMATOLOGY, 2003, 42 : 98 - 98
  • [49] Long-term safety of fully human anti-TNF adalimumab in worldwide rheumatoid arthritis clinical trials
    Schiff, MH
    Burmester, GR
    Pangan, AL
    Kupper, H
    Spencer-Green, G
    Kent, JD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S297 - S297
  • [50] Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis
    Lu, XiaoQin
    Hu, Rui
    Peng, Lin
    Liu, MengSi
    Sun, Zhen
    FRONTIERS IN IMMUNOLOGY, 2021, 12
12345